These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2780466)
21. Pizotifen in the prophylaxis of cyclical vomiting. Salmon MA; Walters DD Lancet; 1985 May; 1(8436):1036-7. PubMed ID: 2859478 [No Abstract] [Full Text] [Related]
22. Experimental and clinical results with pizotifen in the treatment of underweight patients. Dolecek R Pharmatherapeutica; 1980; 2(6):363-71. PubMed ID: 7433478 [No Abstract] [Full Text] [Related]
23. [Significance of the contribution of pizotifen in correcting appetite disorders and weight insufficiencies]. Blouza Chachoub S; Achour A; Ben Mansour A; Fareh N; Nagati K; Kallal Z Tunis Med; 1989 Mar; 67(3):207-12. PubMed ID: 2756581 [No Abstract] [Full Text] [Related]
24. Long-term administration of pizotifen to migraine patients: effects on oral glucose tolerance tests and on insulin levels. Cerdan A; Acosta M; Jolin T; Spain M Headache; 1975 Jul; 15(2):126-8. PubMed ID: 1150429 [No Abstract] [Full Text] [Related]
25. Use of pizotifen in severe migraine: a long-term study. Peet KM Curr Med Res Opin; 1977; 5(2):192-9. PubMed ID: 340139 [TBL] [Abstract][Full Text] [Related]
26. [Pizotifen (Sandomigran) used in the treatment of parkinsonian tremor (preliminary communication)]. Friedman A Neurol Neurochir Pol; 1978; 12(3):263-7. PubMed ID: 683431 [TBL] [Abstract][Full Text] [Related]
27. [Migraine prevention by a calcium channel blocker. Results of a double-blind study of flunarizine vs. pizotifen]. Wörz R; Drillisch C MMW Munch Med Wochenschr; 1983 Jul; 125(32-33):711-14. PubMed ID: 6415411 [No Abstract] [Full Text] [Related]
28. Stimulus-sensitive paroxysmal dyskinesias associated with a thalamic infarct. Nijssen PC; Tijssen CC Mov Disord; 1992 Oct; 7(4):364-6. PubMed ID: 1484533 [No Abstract] [Full Text] [Related]
29. Platelet alpha-adrenergic receptor activity and pizotifen in migrainous children. Bond PA; Salmon MA Cephalalgia; 1985 Mar; 5(1):25-9. PubMed ID: 2985264 [TBL] [Abstract][Full Text] [Related]
30. Flunarizine-pizotifen single-dose double-blind cross-over trial in migraine prophylaxis. Cerbo R; Casacchia M; Formisano R; Feliciani M; Cusimano G; Buzzi MG; Agnoli A Cephalalgia; 1986 Mar; 6(1):15-8. PubMed ID: 3516406 [TBL] [Abstract][Full Text] [Related]
31. Flunarizine vs. pizotifen in migraine prophylaxis: a review of comparative studies. Spierings EL; Messinger HB Cephalalgia; 1988; 8 Suppl 8():27-30. PubMed ID: 3180199 [TBL] [Abstract][Full Text] [Related]
32. Long-term effect of pizotifen treatment on growth hormone levels of underweight children, including those with anorexia nervosa. Dolecek R; Janstová V Pharmatherapeutica; 1985; 4(2):81-7. PubMed ID: 4059293 [TBL] [Abstract][Full Text] [Related]
33. Comparison of flunarizine (Sibelium) and pizotifen (Sandomigran) in migraine treatment: a double-blind study. Louis P; Spierings EL Cephalalgia; 1982 Dec; 2(4):197-203. PubMed ID: 6760980 [TBL] [Abstract][Full Text] [Related]
34. Antiserotonin agents in the treatment of migraine. Prusiński A; Klimek A Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):189-93. PubMed ID: 1107969 [TBL] [Abstract][Full Text] [Related]
35. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone. Cleland PG; Barnes D; Elrington GM; Loizou LA; Rawes GD Eur Neurol; 1997; 38(1):31-8. PubMed ID: 9252796 [TBL] [Abstract][Full Text] [Related]